Skip to main content
Clinical Trials/NCT00980993
NCT00980993
Withdrawn
Not Applicable

Pilot Study on the Quantification of Respiratory-induced Prostate Motion During Radiation Therapy Using Continuous Real-time Tracking

Oregon Health and Science University1 site in 1 countryStarted: September 2012Last updated:
ConditionsProstate Cancer

Overview

Phase
Not Applicable
Status
Withdrawn
Locations
1
Primary Endpoint
Motion amplitude

Overview

Brief Summary

Patient anatomy and position during the course of radiation therapy can vary from those used for treatment planning; a function of patient movement, uncertainty in positioning system, and organ motion. Traditionally, treatment margins are designed to compensate for interfraction prostate setup variability. This approach has the potential to lower the overall effectiveness of treatment because the prostate gland is a continuously moving target whose motion cannot be accurately accounted for solely on the basis of interfraction movement. More recently, the dosimetric relevance of intra-fraction prostate motion has been recognized, and may be compensated for by continuous real-time adaptive radiation therapy afforded by the Calypso 4D Localization System™. In the current study, the investigators propose to characterize intrafraction prostate motion. The investigators hypothesize that intrafraction prostate motion is correlated with respiratory motion.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Histologically confirmed stage I-III adenocarcinoma of the prostate gland
  • Age \> 18 years. Males of all races and ethnic groups
  • Scheduled to receive radiation for definitive therapy
  • Three (3) electromagnetic transponders implanted into prostate gland

Exclusion Criteria

  • Does not satisfy inclusion criteria

Outcomes

Primary Outcomes

Motion amplitude

Time Frame: Continuously during radiation administration (generally 8 to 15 minutes in duration)

Measured at frequency of 10Hz

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials